Clin Lymphoma Myeloma Leuk
-
Publication Venue For
- Lenalidomide Plus Hypomethylating Agent as a Treatment Option in Acute Myeloid Leukemia With Recurrent Genetic Abnormalities-AML With inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM.. 20:24-30. 2020
- Phase I Study of the Combination of Bendamustine, Rituximab, and Pixantrone in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma.. 18:679-686. 2018
- Heterogeneity of Second-Line Treatment for Patients With Multiple Myeloma in the Connect MM Registry (2010-2016).. 18:480-485.e3. 2018
- Consolidation Radiation Therapy for Patients With Advanced Hodgkin Lymphoma in Complete Metabolic Response According to PET-CT or Gallium Imaging.. 18:145-151. 2018
- Analysis of Common Eligibility Criteria of Randomized Controlled Trials in Newly Diagnosed Multiple Myeloma Patients and Extrapolating Outcomes.. 17:575-583.e2. 2017
- Final Results of a Phase 1 Study of Vorinostat, Pegylated Liposomal Doxorubicin, and Bortezomib in Relapsed or Refractory Multiple Myeloma.. 17:424-432. 2017
- Can We Cure Light Chain Deposition Disease of the Kidneys?-A Review and Case Report of a Patient Treated With a Triple Transplant Approach.. 16:e95-e100. 2016
- Oral Debio1143 (AT406), an antagonist of inhibitor of apoptosis proteins, combined with daunorubicin and cytarabine in patients with poor-risk acute myeloid leukemia--results of a phase I dose-escalation study.. 15:443-449. 2015
- Connect MM Registry: The Importance of Establishing Baseline Disease Characteristics.. 15:368-376. 2015
- Quantitative measures of physical functioning after autologous hematopoietic stem cell transplantation in multiple myeloma: a feasibility study.. 15:103-109. 2015
- Small lymphocytic lymphoma presenting as a paraneoplastic syndrome with acute central nervous system demyelination.. 14:e131-e135. 2014
- The development of a myeloablative, reduced-toxicity, conditioning regimen for cord blood transplantation.. 14:e1-e5. 2014
- Sequential lymphomas or clonally unrelated richter syndrome of chronic lymphocytic leukemia into mantle cell lymphoma.. 13:606-609. 2013
- A Phase II trial of gemcitabine and mitoxantrone for patients with acute myeloid leukemia in first relapse.. 10:473-476. 2010
- The United States Cutaneous Lymphoma Consortium (USCLC).. 10 Suppl 2:S88-S89. 2010
- Phase I study of temozolomide and laromustine (VNP40101M) in patients with relapsed or refractory leukemia.. 10:211-216. 2010